EYPT News and Press, EyePoint Pharmaceuticals Inc. From 11/17/21

Shares of Eyepoint Pharma (EYPT +27.0%) have soared today even as the company late last night priced a $100M public offering of 4M shares. Trading in the company today is much higher than usual. As of 1142a ET, ~7.8M shares had traded hands. Average daily volumne is 413,290. Shares slumped wh...

Gainers: InMed Pharmaceuticals (NASDAQ:INM) +47%, EyePoint Pharmaceuticals (NASDAQ:EYPT) +24%, Varex Imaging (NASDAQ:VREX) +12%, OptiNose (NASDAQ:OPTN) +10%, Talkspace (NASDAQ:TALK) +7%. Losers: Cassava Sciences (NASDAQ:SAVA) -26%, Eloxx Pharm...

EyePoint Pharmaceuticals (NASDAQ:EYPT) has priced its public offering of ~4M shares of common stock at $13.75/share and pre-funded warrants to purchase up to 3,272,727 common shares at $13.74/each pre-funded warrant. Expected gross proceeds are ~$100.3M. Underwriters' over-allotment is an add...

WATERTOWN, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced the pricing of an underwritt...

EyePoint Pharmaceuticals (NASDAQ:EYPT) has launched an underwritten public offering of $100M of shares of its common stock. Actual size and other terms of the offering are yet to be determined. Underwriters may be granted a 30-day option to purchase up to an additional $15M of common shares. ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dollar Tree (NASDAQ: DLTR ) stock is taking off on Monday thanks to news that an activist investor is pushing for change at the discount retail company. Source: digitalreflections / Shutterstock.com Mantle Ri...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Trulieve Cannabis (OTCMKTS: TCNNF ) stock is taking off on Monday and we’re diving into what has investors smiling today! Source: Shutterstock The big news that has investors in TCNNF stock excited come...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips EyePoint Pharmaceuticals (NASDAQ: EYPT ) stock is heading higher on Monday thanks to results from a Phase 1 clinical trial. Source: Shutterstock EyePoint Pharmaceuticals released interim results from its clin...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We’re getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday! Source: Eric Urquhart/Shutterstock.com Moving stocks today are earnings ...

EyePoint Pharmaceuticals (NASDAQ:EYPT) announces six-month interim data from the DAVIO Phase 1 clinical trial of EYP-1901, for the treatment of wet age-related macular degeneration (wet AMD). The data were presented at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting. Six-month...